FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?

FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?

Abstract Purpose The value of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)-positron emission tomography (PET)-radiomics in the outcome assessment of patients with recurrent glioblastoma (rGBM) has not been evaluated until now. The aim of this study was to evaluate whether a prognostic model based on FET-...

Full description

Bibliographic Details
Main Authors: Montserrat Carles, Ilinca Popp, Michael Maximilian Starke, Michael Mix, Horst Urbach, Tanja Schimek-Jasch, Franziska Eckert, Maximilian Niyazi, Dimos Baltas, Anca L. Grosu
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Radiation Oncology
Subjects:
Recurrent-glioblastoma
FET-PET
Radiomics
Re-irradiation
Online Access:https://doi.org/10.1186/s13014-020-01744-8

Internet

https://doi.org/10.1186/s13014-020-01744-8

Similar Items